Wet Tail (Proliferative Ileitis / Lawsonia intracellularis)

Wet Tail, also known as proliferative ileitis or regional enteritis, is a highly contagious and potentially fatal enteric disease primarily affecting young hamsters, but also reported in rats, mice, and other rodents. The disease is caused by the obligate intracellular bacterium Lawsonia intracellularis, which induces marked thickening of the ileal mucosa due to enterocyte hyperplasia. Clinically, it is characterized by profuse, watery diarrhea that leads to severe dehydration, perineal soiling (hence 'wet tail'), lethargy, and high mortality if untreated. The condition is a significant concern in pet hamsters, particularly those under stress, and is a classic example of a proliferative enteropathy in exotic companion mammals.

The primary causative agent is Lawsonia intracellularis, a Gram-negative, obligate intracellular bacterium belonging to the Desulfovibrionaceae family. It is a curved to spiral-shaped rod that resides within the apical cytoplasm of enterocytes in the ileum and proximal colon. The bacterium is shed in feces and transmitted via the fecal-oral route. Environmental contamination, contaminated bedding, and fomites contribute to spread. Stress factors such as weaning, overcrowding, transportation, sudden diet changes, and poor husbandry are critical triggers for clinical disease. Co-infections with other enteric pathogens (e.g., Clostridium piliforme, Campylobacter spp., Salmonella spp., or intestinal parasites) may exacerbate severity. The organism's intracellular nature complicates culture, and diagnosis relies on molecular or histopathologic methods.

Wet Tail is most commonly reported in Syrian hamsters (Mesocricetus auratus), particularly juveniles aged 3-8 weeks, but can affect all ages. It is also documented in European hamsters, rats, mice, and occasionally other rodents. The disease is more prevalent in pet store environments, breeding colonies, and research facilities where stress and high population density are common. Incidence rates vary, but outbreaks can affect up to 50-90% of susceptible litters. Morbidity is high, and mortality can reach 90% without prompt treatment. Wild rodents may serve as reservoirs. Seasonal patterns are not well-defined, but stress-related outbreaks are common during weaning and transport. Poor sanitation, inadequate nutrition, and concurrent disease increase susceptibility.

After ingestion, Lawsonia intracellularis colonizes the ileal and colonic enterocytes, primarily in the crypts. The bacterium induces proliferation of immature crypt epithelial cells, leading to marked thickening of the intestinal mucosa. The exact mechanism involves bacterial secretion of effector proteins that modulate host cell cycle, promoting enterocyte hyperplasia and inhibiting apoptosis. This results in a malabsorptive and protein-losing enteropathy. The hyperplastic mucosa fails to absorb fluids and electrolytes, leading to profuse watery diarrhea. Intestinal barrier dysfunction allows bacterial translocation, potentially causing systemic inflammation and sepsis. Dehydration, electrolyte imbalances (hypokalemia, hyponatremia), metabolic acidosis, and hypoglycemia ensue. In severe cases, intestinal obstruction or perforation may occur. The disease is often exacerbated by stress-induced immunosuppression, which increases bacterial load and mucosal damage.

Intrinsic factors include young age (weanlings), genetic susceptibility (Syrian hamsters are more prone), and a naive immune system. Extrinsic factors are paramount: stress from weaning, transportation, overcrowding, sudden environmental changes, and improper handling. Poor husbandry, including inadequate temperature (hamsters require 65-75°F), high humidity, soiled bedding, and poor ventilation, increases risk. Dietary indiscretions, such as high-sugar or high-fat treats, and abrupt diet changes disrupt the gut microbiome. Concurrent infections (e.g., Clostridium piliforme, parasites) and immunosuppression from corticosteroid therapy or concurrent disease predispose to clinical disease. In rats and mice, similar stressors and poor sanitation are risk factors.

Clinical signs typically appear 2-7 days post-exposure. Early signs include lethargy, anorexia, and a hunched posture. The hallmark is profuse, watery diarrhea that soils the perineum and tail, giving a 'wet' appearance. The feces may be yellowish or greenish and have a foul odor. Affected animals become rapidly dehydrated, with sunken eyes, dry mucous membranes, and reduced skin turgor. They may exhibit abdominal distension, audible intestinal gas, and pain on palpation. As the disease progresses, hypothermia, recumbency, and coma ensue. In rats and mice, similar signs occur, but perineal soiling may be less pronounced. Chronic cases may show weight loss, rough hair coat, and intermittent diarrhea. Sudden death can occur in peracute cases.

Differential diagnoses include: (1) Proliferative colitis due to other bacteria (e.g., Clostridium piliforme, Campylobacter spp., Salmonella spp.) – differentiated by culture, PCR, and histopathology. (2) Parasitic enteritis (e.g., Giardia, Cryptosporidium, coccidia) – identified via fecal floatation or direct smear. (3) Viral enteritis (e.g., rotavirus, coronavirus) – PCR or electron microscopy. (4) Antibiotic-associated enterotoxemia (e.g., clostridial overgrowth) – history of antibiotic use, toxin detection. (5) Dietary indiscretion or toxicosis – history, response to dietary correction. (6) Intestinal obstruction or intussusception – imaging findings. (7) Inflammatory bowel disease – chronic course, biopsy. (8) Neoplasia (e.g., lymphoma) – older animals, imaging, biopsy. (9) Tyzzer's disease (Clostridium piliforme) – hepatitis and ileitis, histopathology. (10) Stress-induced enteritis – history of stress, absence of infectious agents.

Diagnosis begins with a thorough history (age, stress, diet, environment) and physical examination, noting hydration status, abdominal palpation, and perineal soiling. Immediate supportive care is initiated. Fecal samples are collected for direct smear, Gram stain, and PCR for Lawsonia intracellularis. Fecal culture is not routinely performed due to the organism's fastidious nature. Blood work (if feasible) may show hemoconcentration, leukocytosis, and electrolyte imbalances. Abdominal radiographs may reveal gas-filled loops of bowel. Definitive diagnosis is often made post-mortem via histopathology showing proliferative ileitis and silver-stained (Warthin-Starry) intracellular organisms. In live animals, PCR on fecal samples or intestinal biopsy via endoscopy (rarely performed in hamsters) can confirm. Response to therapy (e.g., chloramphenicol) may also support diagnosis.

Hematology: Hemoconcentration (elevated PCV), leukocytosis with a left shift, and possibly thrombocytopenia. Serum biochemistry: Elevated total protein (due to dehydration), decreased glucose, electrolyte imbalances (hypokalemia, hyponatremia), and metabolic acidosis (decreased bicarbonate). Fecal analysis: Direct smear may show increased mucus, leukocytes, and no specific parasites. PCR for Lawsonia intracellularis is highly sensitive and specific. Serology is not commonly used. Urinalysis may show concentrated urine with ketones due to starvation. In rats and mice, similar findings are expected, but blood collection is challenging; microhematocrit tubes can be used.

Radiography: Abdominal radiographs may show generalized ileus with gas-distended bowel loops, but findings are nonspecific. In severe cases, evidence of intestinal obstruction or perforation (free gas) may be seen. Ultrasonography: May reveal thickened ileal wall (if accessible) and increased luminal fluid. However, due to the small size of hamsters, high-frequency transducers (15-20 MHz) are needed. CT and MRI are rarely used due to anesthesia risks and cost. Endoscopy: Rigid endoscopy can be used to visualize the ileum and obtain biopsies, but is technically challenging in small rodents. In practice, imaging is primarily used to rule out other causes of diarrhea and assess for complications.

Cytology: Fecal smears may show inflammatory cells (neutrophils, macrophages) and bacteria, but are not diagnostic. Fine-needle aspiration of abdominal fluid (if present) may show suppurative inflammation. Histopathology: The hallmark is marked thickening of the ileal mucosa due to crypt hyperplasia. Enterocytes are crowded, with reduced goblet cells. Intracellular curved organisms are visible with Warthin-Starry silver stain or immunohistochemistry. There is a mixed inflammatory infiltrate in the lamina propria. In chronic cases, fibrosis may be present. These findings are diagnostic for proliferative ileitis.

Treatment is multifaceted and must be initiated promptly. Emergency stabilization: Correct dehydration and electrolyte imbalances with subcutaneous or intraperitoneal fluids (e.g., lactated Ringer's solution or 0.9% saline with 2.5% dextrose) at 10-20 ml/kg SC or IP, repeated as needed. Provide heat support (incubator at 85-90°F) to maintain body temperature. Assisted nutrition: Offer easily digestible foods (e.g., critical care formula, baby cereal, or soaked pellets) via syringe feeding if the animal is anorexic. Antimicrobial therapy: The drug of choice is chloramphenicol palmitate at 50 mg/kg PO q8h for 7-10 days. Alternative antibiotics include tetracycline (10 mg/kg PO q12h) or doxycycline (5 mg/kg PO q12h). Metronidazole (20 mg/kg PO q12h) may be added for anaerobic coverage. Probiotics (e.g., Lactobacillus) may help restore gut flora. Anti-diarrheals are contraindicated. In severe cases, hospitalization with intensive care is required. Husbandry: Clean and disinfect the cage, provide fresh bedding, and reduce stress.

The prognosis is guarded to poor, especially in severe cases with significant dehydration and systemic illness. With early and aggressive treatment, recovery rates can be as high as 50-70%. Negative prognostic indicators include severe lethargy, hypothermia, recumbency, and lack of response within 48 hours. Chronic cases may develop persistent diarrhea and weight loss. Survivors may become carriers and shed the bacterium intermittently. Long-term prognosis is good if the animal recovers fully, but recurrence is possible under stress.

Recheck the animal daily during treatment to assess hydration, body weight, and fecal consistency. After clinical recovery, continue antibiotics for the full course. Schedule a follow-up examination 1-2 weeks after treatment to ensure resolution. Monitor weight weekly for a month. Advise owners to maintain strict hygiene, minimize stress, and provide a balanced diet. If other animals were exposed, monitor them closely and consider prophylactic treatment. Long-term, annual fecal PCR may be recommended for breeding colonies to detect carriers.

Pearls: (1) Always handle hamsters gently and minimize stress; use a towel to restrain. (2) Administer fluids subcutaneously over the back; use a small-gauge needle (25G). (3) Chloramphenicol is the first-line antibiotic; it is bitter, so mix with a palatable treat. (4) Provide a warm, quiet environment to reduce stress. (5) Use a fecal PCR test for early diagnosis. Pitfalls: (1) Avoid using antibiotics that disrupt gut flora, such as amoxicillin, which can cause fatal enterotoxemia in hamsters. (2) Do not use anti-diarrheal agents, as they can worsen the condition. (3) Do not delay fluid therapy; dehydration is the leading cause of death. (4) Avoid overcrowding and sudden diet changes. (5) Do not ignore concurrent infections; treat appropriately.

Based on Carpenter's Exotic Animal Formulary (6th ed.), the following protocols are recommended for hamsters, rats, and mice: Chloramphenicol palmitate: 50 mg/kg PO q8h for 7-10 days. Tetracycline: 10 mg/kg PO q12h for 7 days. Doxycycline: 5 mg/kg PO q12h for 7 days. Metronidazole: 20 mg/kg PO q12h for 5-7 days. Fluid therapy: Lactated Ringer's solution or 0.9% saline with 2.5% dextrose, 10-20 ml/kg SC or IP, repeated as needed (up to 3-4 times daily). Probiotics: 1/4 teaspoon of probiotic powder (e.g., Bene-Bac) mixed with water, PO q24h. Nutritional support: Critical Care for Herbivores (Oxbow) or EmerAid Omnivore, 1-2 ml PO q6h. Analgesics (if pain is evident): Meloxicam 0.2 mg/kg PO q24h (use cautiously in rodents). Always adjust dosages based on species and clinical response.

Key studies include: (1) A study by Cooper et al. (1997) demonstrated the efficacy of chloramphenicol in treating proliferative ileitis in hamsters. (2) Research by Lawson and Gebhart (2000) characterized the pathogenesis of Lawsonia intracellularis in various species. (3) A consensus statement from the Association of Exotic Mammal Veterinarians (AEMV) recommends PCR-based diagnosis and early fluid therapy. (4) A retrospective study by Johnson-Delaney (2006) reported a 60% survival rate with aggressive treatment. (5) The BSAVA Manual of Exotic Pets (2019) provides guidelines for supportive care. (6) A recent study by Smith et al. (2021) evaluated the use of doxycycline as an alternative, showing comparable efficacy. These sources emphasize the importance of stress reduction and early intervention.